for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BUZZ-Aeterna Zentaris Inc: Q2 revenue soars

** Canadian drug developer’s U.S.-listed shares up as much as 33 pct to $2.30; second-biggest pct gainer on Nasdaq

** Q2 revenue rises to $243,000 from $96,000, helped by expanded contract for blood test Apifiny

** Apifiny is cancer-specific blood test to assess the risk of prostate cancer

** Says looking to evaluate various strategic and financing alternatives

** Up to Thursday’s close, stock had fallen 51.9 pct this year

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up